Correlation Between Memphis Pharmaceuticals and Reacap Financial

Can any of the company-specific risk be diversified away by investing in both Memphis Pharmaceuticals and Reacap Financial at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Memphis Pharmaceuticals and Reacap Financial into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Memphis Pharmaceuticals and Reacap Financial Investments, you can compare the effects of market volatilities on Memphis Pharmaceuticals and Reacap Financial and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Memphis Pharmaceuticals with a short position of Reacap Financial. Check out your portfolio center. Please also check ongoing floating volatility patterns of Memphis Pharmaceuticals and Reacap Financial.

Diversification Opportunities for Memphis Pharmaceuticals and Reacap Financial

0.71

Correlation Coefficient

Memphis Pharmaceuticals  Reacap Financial

Poor diversification

The 3 months correlation between Memphis and Reacap is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Memphis Pharmaceuticals and Reacap Financial Investments in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Reacap Financial Inv and Memphis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Memphis Pharmaceuticals are associated (or correlated) with Reacap Financial. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Reacap Financial Inv has no effect on the direction of Memphis Pharmaceuticals i.e., Memphis Pharmaceuticals and Reacap Financial go up and down completely randomly.

Pair Corralation between Memphis Pharmaceuticals and Reacap Financial

Assuming the 90 days trading horizon Memphis Pharmaceuticals is expected to under-perform the Reacap Financial. In addition to that, Memphis Pharmaceuticals is 2.4 times more volatile than Reacap Financial Investments. It trades about -0.12 of its total potential returns per unit of risk. Reacap Financial Investments is currently generating about -0.15 per unit of volatility. If you would invest  691.00  in Reacap Financial Investments on September 25, 2024 and sell it today you would lose (30.00) from holding Reacap Financial Investments or give up 4.34% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	94.44%
Values	Daily Returns

Memphis Pharmaceuticals  vs.  Reacap Financial Investments

Memphis Pharmaceuticals

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Memphis Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Memphis Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Reacap Financial Inv

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Reacap Financial Investments are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile technical and fundamental indicators, Reacap Financial may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Memphis Pharmaceuticals and Reacap Financial

The main advantage of trading using opposite Memphis Pharmaceuticals and Reacap Financial positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Memphis Pharmaceuticals position performs unexpectedly, Reacap Financial can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Reacap Financial will offset losses from the drop in Reacap Financial's long position.

The idea behind Memphis Pharmaceuticals and Reacap Financial Investments pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.